Why is SMS Pharma. falling/rising?

As of 11-Jul, SMS Pharmaceuticals Ltd is currently priced at 237.50, reflecting a slight increase of 0.45, or 0.19%. The stock has recently shown a trend reversal, gaining after four consecutive days of decline. However, it has underperformed its sector by 0.39% today. The stock's performance over the past week indicates a decline of 2.66%, and over the past month, it has decreased by 7.80%. Despite these short-term challenges, the company has reported positive results for the last nine consecutive quarters, with significant metrics such as an operating profit to interest ratio at its highest and a low debt-equity ratio. However, the stock's long-term growth prospects appear limited, as net sales and operating profit have grown at rates of 13.70% and 12.53%, respectively, over the last five years, which may contribute to investor caution.
In the broader market context, the Sensex has experienced a minor decline of 1.12% over the past week, while SMS Pharmaceuticals has underperformed this benchmark. The stock's year-to-date performance shows a slight decline of 0.98%, contrasting with the Sensex's gain of 5.58%. The increase in pledged promoter shares, which now stands at 37.6% and has risen by 18.2% over the last quarter, adds to the downward pressure on the stock, particularly in a falling market. This combination of factors, including the recent trend reversal and the company's solid quarterly performance, suggests that while there are positive indicators, the overall sentiment remains cautious due to long-term growth concerns and high pledged shares.